Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v3-EN
Language English English
Date Updated 2021-11-25 2021-09-30
Drug Identification Number 02469561 02469561
Brand name TEVA-FINGOLIMOD TEVA-FINGOLIMOD
Common or Proper name FINGOLIMOD 0.5MG CAPS FINGOLIMOD 0.5MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients FINGOLIMOD FINGOLIMOD
Strength(s) 0.5MG 0.5MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30UD 30UD
ATC code L04AA L04AA
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2021-09-22 2021-09-22
Estimated end date 2022-01-31 2021-12-31
Actual end date 2021-11-24
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Item is short-dated/expiring Item is short-dated/expiring
Health Canada comments